| OMB Number | Title |
|---|
| 0910-0929 |
A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising |
| 0910-0928 |
Institutional Review Boards; Cooperative Research - PROPOSED RULE |
| 0910-0927 |
Labeling Requirements for Approved or Conditionally Approved New Animal Drugs - Proposed rule. |
| 0910-0926 |
PROPOSED RULE: Protection of Human Subjects and Institutional Review Boards; Harmonization with the Common Rule |
| 0910-0925 |
Investigational New Drug Applications: Exemptions for Clinical Investigations to Evaluate a Drug Use of a Product Lawfully Marketed as a Conventional Food, Dietary Supplement, or Cosmetic. |
| 0910-0924 |
Investigational New Drug Applications: Annual Reporting |
| 0910-0923 |
Adding Requirement to Submit Mail Tracking Number for Articles of Food Arriving by International Mail and Timeframe for Post-Refusal and Post-Hold Submissions |
| 0910-0922 |
Medical Devices--Voluntary Improvement Program |
| 0910-0921 |
List of US Manufacturers of Specific CVM-Regulated Products with Interest in Exporting Covered Products to China |
| 0910-0920 |
Quantitative Research on Front of Package Labeling on Packaged Foods |
| 0910-0919 |
Assessing Physiological, Neural and Self-Reported Response to Tobacco Education Messages |
| 0910-0918 |
Endorser Status and Actual Use in Direct-to-Consumer Television Ads |
| 0910-0917 |
Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion |
| 0910-0916 |
Perceptions of Prescription Drug Products with Medication Tracking Capabilities |
| 0910-0915 |
The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 (Outcomes Study) |
| 0910-0914 |
Monthly Monitoring Study |
| 0910-0913 |
Tobacco Product Manufacturing Practice Requirements |
| 0910-0912 |
Yale-Mayo Clinic Centers of Excellence in Regulatory Science and Innovation B12 Pediatric Device Survey |
| 0910-0911 |
Substances Generally Recognized as Safe: Best Practices for Convening a GRAS Panel |
| 0910-0910 |
Text Analysis of Proprietary Drug Name Interpretations |
| 0910-0909 |
Standardized Reporting Forms for Federally Funded Public Health Projects and Agreements |
| 0910-0908 |
Targeted Mechanism of Action Presentations in Prescription Drug Promotion |
| 0910-0907 |
Study of How Consumers Use Flavors to Make Inferences About Electronic Nicotine Delivery System (ENDS) Product Qualities and Intentions to Use (Phase 2) |
| 0910-0906 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases - FINAL RULE |
| 0910-0905 |
Quantitative Research on a Voluntary Symbol Depicting the Nutrient Content Claim "Healthy" on Packaged Food |
| 0910-0904 |
Compounding Animal Drugs from Bulk Drug Substances |
| 0910-0903 |
Infant Formula Enforcement Discretion Policy |
| 0910-0902 |
Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials |
| 0910-0901 |
Medical Conference Attendees’ Observations about Prescription Drug Promotion |
| 0910-0900 |
Study of Disclosures to Health Care Providers Regarding Data that Do Not Support Unapproved Use of an Approved Prescription Drug |
| 0910-0899 |
Survey of Drug Product Manufacturing, Processing, and Packing Facilities |
| 0910-0898 |
Laboratory Accreditation for Analyses of Foods |
| 0910-0897 |
Study of Multiple Indications in Direct-to-Consumer Television Advertisements |
| 0910-0896 |
Empirical Study of Promotional Implications of Proprietary Prescription Drug Names |
| 0910-0895 |
Assessment of Terms and Phrases Commonly Used in Prescription Drug Promotion |
| 0910-0894 |
Endorser Status and Explicitness of Payment in Direct-to-Consumer Promotion |
| 0910-0893 |
Right to Try Act: Reporting Requirements |
| 0910-0892 |
Health Care Providers Understanding of Opioid Analgesic Abuse-Deterrent Formulations: Phase 2 and 3 Surveys |
| 0910-0891 |
Generic Clearance for Qualitative Data to Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and Feed |
| 0910-0890 |
Healthcare Provider Perception of Boxed Warning Information Survey |
| 0910-0889 |
Accreditation Scheme for Conformity Assessment Program |
| 0910-0888 |
Importation of Prescription Drugs |
| 0910-0887 |
Center for Tobacco Products, Food and Drug Administration Funded Trainee/Scholar Survey |
| 0910-0886 |
Requests for Nonbinding Feedback After Certain FDA Inspections of Device Establishments |
| 0910-0885 |
Study of Oncology Indications in Direct-to-Consumer Television Advertising |
| 0910-0884 |
List of US Manufacturers of Specific CVM-Regulated Products with Interest in Exporting Covered Products to China |
| 0910-0883 |
Obtaining Information to Understand and Challenges and Opportunities Encountered by Compounding Outsourcing Facilities |
| 0910-0882 |
Collection of Conflict of Interest Information for Participation in Food and Drug Administration Non-Employee Fellowship and Traineeship Programs |
| 0910-0881 |
Web-Based Pilot Survey to Assess Allergy to Cosmetics in the United States |
| 0910-0880 |
Experimental Study on Measuring Consumer Comprehension of Displays of Harmful and Potentially Harmful Constituents (HPHCs) in Tobacco Products and Tobacco Smoke |
| 0910-0879 |
Premarket Tobacco Product Applications and Recordkeeping Requirements |
| 0910-0878 |
Sunlamp Products; Proposed Amendment to § 1002.1 (Record and Reporting Requirements) and § 1040.20 (Performance Standard) |
| 0910-0877 |
Required Warnings for Cigarette Packages and Advertisements |
| 0910-0876 |
Generic Clearance for Quick Turnaround Testing of Communication Effectiveness |
| 0910-0875 |
Physician Interpretation of Information About Prescription Drugs in Scientific Publications vs. Promotional Pieces |
| 0910-0874 |
Disease Awareness and Prescription Drug Promotion on Television |
| 0910-0873 |
Investigation of Consumer Perceptions of Expressed Modified Risk Claims |
| 0910-0872 |
Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites |
| 0910-0871 |
Obtaining Information for Evaluating Nominated Bulk Drug Substances for Use in Compounding Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act |
| 0910-0870 |
Electronic Format for Submissions; Promotional Labeling and Advertising Materials for Human Prescription Drugs |
| 0910-0869 |
Healthcare Professional Survey of Professional Prescription Drug Promotion |
| 0910-0868 |
Assessment of Combination Product Review Practices |
| 0910-0867 |
Survey of Current Manufacturing Practices for the Cosmetics Industry |
| 0910-0866 |
Experimental Study of Cigarette Warnings |
| 0910-0865 |
Generic Clearance for Quantitative Testing for the Development of FDA Communications (CFSAN) |
| 0910-0864 |
Disclosures of Descriptive Presentation in Professional Oncology Prescription Drug Promotion |
| 0910-0863 |
Surveys and Interviews with Investigational New Drug Sponsors to Assess Current Communication Practices with FDA Review Staff Under the Sixth Authorization of the Prescription Drug User Fee Act |
| 0910-0862 |
Labeling of Red Blood Cell Units with Historical Antigen Typing Results |
| 0910-0861 |
Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads |
| 0910-0860 |
Disclosures in Professional and Consumer Prescription Drug Promotion |
| 0910-0859 |
Drug Supply Chain Security Act (DSCSA) Pilot Progam |
| 0910-0858 |
Human Drug Compounding, Repackaging, and Related Activities Regarding Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act |
| 0910-0857 |
Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities Questions and Answers |
| 0910-0856 |
Medical Product Communications That Are Consistent With the Food and Drug Administration Required Labeling -Questions and Answers |
| 0910-0855 |
National Agriculture and Food Defense Strategy Survey |
| 0910-0854 |
Quality Facility Attestation |
| 0910-0853 |
Utilization of Adequate Provision Among Low to Non-Internet Users |
| 0910-0852 |
Transfer of a Premarket Notification Clearance |
| 0910-0851 |
Evaluation of the Food and Drug Administration’s Point-of-Sale Campaign |
| 0910-0850 |
Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based in Vitro Diangostics |
| 0910-0849 |
Consumer and Healthcare Professional Identification of and Responses to Deceptive Prescription Drug Promotion |
| 0910-0848 |
Experimental Study on Warning Statements for Cigarette Graphic Health Warnings |
| 0910-0847 |
Data To Support Social and Behavioral Research as Used by the Food and Drug Administration |
| 0910-0846 |
Character-Space-Limited Online Prescription Drug Communications |
| 0910-0845 |
Draft Guidance for Industry; How to Prepare a Pre-Request for Designation (Pre-RFD) |
| 0910-0844 |
De Novo Classification Process (Evaluation of Automatic Class III Designation) |
| 0910-0843 |
GFI: E6(R2) Good Clinical Practice; International Council for Harmonisation |
| 0910-0842 |
Import Trade Auxiliary Communication System |
| 0910-0841 |
Donor Risk Assessment Questionnaire for the FDA/National Heart, Lung, and Blood Institute - Sponsored Transfusion-Transmissible Infections Monitoring System - Risk Factor Elicitation |
| 0910-0840 |
Voluntary Qualified Importer Program |
| 0910-0839 |
Establishing and Maintaining a List of U.S. Milk and Milk Product, Seafood,Infant Formula, and Formula for Young Children Manufacturers/Processorswith Interest in Exporting to China |
| 0910-0838 |
Postmarketing Safety Reports for Human Drug and Biological Products: Electronic Submission Requirements |
| 0910-0837 |
Index of Legally Marketed Unapproved New Animal Drugs for Minor Species |
| 0910-0836 |
REPORTING INFORMATION REGARDING FALSIFICATION OF DATA |
| 0910-0835 |
Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner |
| 0910-0834 |
Postmarketing Safety Reporting for Combination Products |
| 0910-0833 |
Food and Drug Administration Advisory Committee Regulations |
| 0910-0832 |
Certification of Identity for Freedom of Information and Privacy Act Requests |
| 0910-0831 |
STUDY: Superimposed Text in Direct-to-Consumer Promotion of Prescription Drugs |
| 0910-0830 |
Tobacco Product Standard: NNN Level of Finished Smokeless Tobacco Products |
| 0910-0829 |
Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Inlcuding Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; Final Rule |
| 0910-0828 |
National Survey of Health Information and Communication |
| 0910-0827 |
Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act |
| 0910-0826 |
Animation in Direct-to-Consumer Advertising |
| 0910-0825 |
Restricted Sale, Distribution, and Use of Sunlamp Products |
| 0910-0824 |
Market Claims in Direct-to-Consumer Prescription Drug Print Ads |
| 0910-0823 |
Medical Device Accessories |
| 0910-0822 |
Tropical Disease Priority Review Vouchers |
| 0910-0821 |
Quantitative Information in Direct-to-Consumer Television Advertisements Survey |
| 0910-0820 |
Comparing Food Safety Knowledge, Attitude and Behavior Among English-Dominant Hispanics, Spanish-Dominant Hispanics, and Other Consumers |
| 0910-0819 |
Experimental Study on Consumer Perceptions of Modified Risk Tobacco Products (MRTP) |
| 0910-0818 |
Hearing, Aging, and Direct-to-Consumer Television Advertisements |
| 0910-0817 |
Gluten-Free Labeling of Fermented or Hydrolyzed Foods |
| 0910-0816 |
Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption - Agricultural Water - FINAL RULE |
| 0910-0815 |
National Panel of Tobacco Consumer Studies |
| 0910-0814 |
Expanded Access to Investigational Drugs for Treatment Use |
| 0910-0813 |
Food Labeling: Nutrition Facts and Supplement Facts labels |
| 0910-0812 |
Mitigation Strategies to Protect Food Against Intentional Adulteration |
| 0910-0811 |
Exempt Infant Formula Production: Current Good Manufacturing Practices (CGMPs), Quality Control Procedures, Conduct of Audits, and Records |
| 0910-0810 |
Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications |
| 0910-0808 |
Food and Drug Administration's Research and Evaluation Survey for the Public Education Campaign on Tobacco among LGBT (RESPECT) |
| 0910-0807 |
Voluntary Labeling Indicating Whether Foods Have or Have Not BeenDerived from Genetically Engineered Plants |
| 0910-0806 |
Pharmaceutical Distribution Supply Chain |
| 0910-0805 |
Electronic User Fee Payment Form Requests |
| 0910-0803 |
Impact of Ad Exposure Frequency on Perception and Mental Processing of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Ads |
| 0910-0802 |
Guidance for Industry on Formal Meetings Between the FDA and Biosimilar Biological Product Sponsors or Applicants |
| 0910-0801 |
Survey of Pharmacists and Patients; Variations in the Physical Characteristics of Generic Drug Pills and Patients' Perceptions |
| 0910-0800 |
Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act |
| 0910-0799 |
Survey on the Occurrence of Foodborne Illness Risks Factors in Selected Institutional Foodservice and Retail Food Stores Facility Types |
| 0910-0797 |
Controlled Correspondence Related to Generic Drug Development |
| 0910-0796 |
Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications |
| 0910-0795 |
Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use - Final Rule |
| 0910-0794 |
Electronic Distribution of Prescribing Information for Human Prescription Drugs, Including Biological Products - Proposed Rule |
| 0910-0793 |
Food and Cosmetic Export Certificates |
| 0910-0792 |
Food Allergen Labeling and Reporting |
| 0910-0791 |
Comparative Price Information in Direct-to-Consumer and Professional Prescription Drug Advertisements |
| 0910-0790 |
Survey of Health Care Practitioners for Device Labeling Format and Content |
| 0910-0789 |
Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food for Animals |
| 0910-0788 |
Evaluation of the Food and Drug Administration's 'Fresh Empire' Multicultural Youth Tobacco Prevention Campaign. |
| 0910-0787 |
Guidance for Industry, Researchers, Patient Groups, and FDA Staff on Meetings with the Office of Orphan Products Development |
| 0910-0786 |
Abbreviated New Drug Applications and 505(b)(2) Applications |
| 0910-0785 |
Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements |
| 0910-0784 |
Risk and Benefit Perception Scale Development |
| 0910-0783 |
Food Labeling; Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments |
| 0910-0782 |
Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments |
| 0910-0781 |
Information Request Regarding pH of Smokeless Tobacco Products |
| 0910-0780 |
Application for Participation in Food and Drug Administration Fellowship Programs |
| 0910-0779 |
Antiparasitic Drug Use and Antiparasitic Resistance Survey |
| 0910-0778 |
Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents |
| 0910-0777 |
GFI: Registration of Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act |
| 0910-0776 |
Registration of Human Drug Compounding Outsourcing Facilities under section 503B of the FFDCA and Associated fees under section 744K |
| 0910-0775 |
Establishing That a Tobacco Product Was Commercially Marketed in the United States As of February 15, 2007 |
| 0910-0774 |
Experimental Study of Proposed Changes to the Nutrition Facts Label Formats |
| 0910-0773 |
Sanitary Transportation of Human and Animal Food |
| 0910-0772 |
Eye Tracking Study of Direct-to-Consumer Prescription Drug Advertisement Viewing |
| 0910-0771 |
GFI: Providing Postmarket Periodic Safety Reports in the International Conference on Harmonisation E2C(R2) Format |
| 0910-0770 |
Postmarketing Safety Reports for Human Drug and Biological Products: Electronic Submission Requirements - Final Rule |
| 0910-0769 |
Submission to CDRH Allegations of Regulatory Misconduct Associated with Medical Devices |
| 0910-0768 |
Deeming Tobacco Products To Be Subject to the FD&C Act |
| 0910-0767 |
Annual Reporting for Custom Device Exemption |
| 0910-0766 |
Safety Assurance Case |
| 0910-0765 |
Expedited Programs for Serious Conditions-Drugs and Biologics |
| 0910-0764 |
Study; Consumer Responses to Nutrition Facts Labels w/Various Footnote Formats and Declaration of Added Sugars |
| 0910-0763 |
Experimental Studies on Consumer Responses to Nutrient Content Claims on Fortified Foods |
| 0910-0762 |
Providing Information About Pediatric Uses of Medical Devices Under Section 515A of the Federal Food, Drug and Cosmetic Act |
| 0910-0761 |
Eye Tracking Experimental Studies to Explore Consumer Use of Food Labeling Information and Consumer Response to Online Surveys |
| 0910-0760 |
Federal-State Food Regulatory Program Standards |
| 0910-0759 |
Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products |
| 0910-0758 |
Final Guidance for Industry on Chemistry, Manufacturing, and Controls Postapproval Manufacturing Changes to be Documented in Annual Reports |
| 0910-0757 |
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products; Proposed Rule |
| 0910-0756 |
Q-Submission and Early Payor Feedback Request Programs for Medical Devices |
| 0910-0755 |
Protection of Human Subjects: Informed Consent; Institutional Review Boards |
| 0910-0754 |
Mailing of Important Information About Drugs |
| 0910-0753 |
Evaluation of the Food and Drug Administration's General Market Youth Tobacco Prevention Campaign |
| 0910-0752 |
Foreign Supplier Verification Programs for Importers of Food for Humans and Animals |
| 0910-0751 |
Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls For Human Food and Food for Animals |
| 0910-0750 |
Accreditation of Third Party Certification Bodies to Conduct Food Safety Audits and Issue Certifications |
| 0910-0749 |
Tobacco Products, User Fees, Requirements for the Submission of Data Needed to Calculate User Fees for Domestic Manufacturers and Importers of Tobacco Products |
| 0910-0748 |
Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations |
| 0910-0747 |
Experimental Study on Consumer Responses to Whole Grain Labeling Statements on Food Packages |
| 0910-0746 |
Review Transparency & Communication for New Molecular Entity NDAs & Original BLAs |
| 0910-0745 |
Tobacco Retailer Training Programs |
| 0910-0744 |
Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Restaurant and Retail Foodservice Facility Types |
| 0910-0743 |
Communicating Composite Scores in Direct-to-Consumer (DTC) Prescription Drug Advertising |
| 0910-0742 |
Proposed Amendment to Laser Product Performance Standard |
| 0910-0741 |
Human Subject Protection; Acceptance of Data from Clinical Studies for Medical Devices |
| 0910-0740 |
Medical Devices: Use of Certain Symbols in Labeling--Glossary to Support the Use of Symbols in Labeling |
| 0910-0739 |
Product Safety Standards--Recordkeeping and Third Party Disclosure Requirements |
| 0910-0738 |
Center for Devices and Radiological Health Appeals Processes |
| 0910-0737 |
Experimental Study: Examination of Corrective Direct-to-Consumer Television Advertising |
| 0910-0736 |
Experimental Study on the Public Display of Lists of Harmful and Potential Harmful Tobacco Constituents |
| 0910-0735 |
Experimental Study on Consumer Responses to Labeling Statements on Food Packages |
| 0910-0734 |
Safety Labeling Changes; Implementation of the Federal Food, Drug, and Cosmetic Act |
| 0910-0733 |
Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring |
| 0910-0732 |
Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under the Federal Food, Drug, and Cosmetic Act |
| 0910-0731 |
Guidance on Meetings with Industry and Investigators on the Research and Development of Tobacco Products |
| 0910-0730 |
Health Care Professional Survey of Prescription Drug Promotion |
| 0910-0729 |
Secure Supply Chain Pilot Program (SSCPP) |
| 0910-0728 |
Labeling of Certain Beers Subject to the Labeling Jurisdiction of the FDA |
| 0910-0727 |
Generic Drug User Fee Program |
| 0910-0726 |
Improving Food Safety and Defense Capacity of the State and Local Level: Review of State and Local Capacities |
| 0910-0725 |
Experimental Study; Health Claims and Disclaimers About the Relationship Between Selenium and Risk of Various Cancers |
| 0910-0724 |
Experimental Study: Disease Information in Branded Promotional Material |
| 0910-0723 |
Revisions to Labeling Requirements for Blood and Blood Components, Including Source Plasma |
| 0910-0722 |
Medical Device Decision Analysis: A Risk-Tolerance Pilot Study |
| 0910-0721 |
Animal Food Labeling; Declaration of Certifiable Color Additives |
| 0910-0720 |
Unique Device Identification System |
| 0910-0719 |
General Licensing Provisions; Section 351(k) Biosimilar Applications |
| 0910-0718 |
Biosimilar User Fee Program |
| 0910-0717 |
SPF Labeling and Testing Requirements for OTC Sunscreen Products |
| 0910-0716 |
Potential Tobacco Product Violations Reporting Form |
| 0910-0715 |
Survey of "Health Care Providers' Responses to Medical Device Labeling" |
| 0910-0714 |
Examination of Online Direct-to-Consumer Prescription Drug Promotion |
| 0910-0713 |
Experimental Study: Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions |
| 0910-0712 |
Data to Support Communications Usability Testing, as Used by the Food and Drug Administration |
| 0910-0711 |
Real Time Surveys of Consumers` Knowledge, Perceptions and Reported Behavior Concerning Foodborne Illness Outbreaks or Food Recalls |
| 0910-0710 |
Data to Support Food and Nutrition Product Communications as Used by the Food and Drug Administration |
| 0910-0709 |
Changes to Reportable Food Registry Reports Under the FDA Food Safety Modernization Act |
| 0910-0708 |
Data to Support Communications to Educate Consumers on How to Safely Purchase Drugs Online |
| 0910-0707 |
Experimental Study of Comparative Direct-to-Consumer (DTC) Advertising |
| 0910-0706 |
Comparing Nutrition Knowledge, Attitude, and Behavior Among English Dominant Hispanics, Spanish Dominant Hispanics, and Other Consumers |
| 0910-0705 |
Section 513(g) Requests for Information |
| 0910-0704 |
Guidance on Consultation Procedures: Foods Derived From New Plant Varieties |
| 0910-0703 |
Experimental Study of Format Variations in the Brief Summary of Direct-to-Consumer (DTC) Print Advertisements |
| 0910-0702 |
Orphan Drug Regulations |
| 0910-0701 |
Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic: Agency Guidance |
| 0910-0700 |
Guidance Medical Device ISO 13485: 2003 Voluntary Audit Report Submission Pilot Program |
| 0910-0699 |
Applications for Food and Drug Administration Approval to Market a New Drug; Revision of Postmarketing Reporting Requirements--Discontinuance |
| 0910-0698 |
National Consumer Surveys on Understanding the Risks and Benefits of FDA-Regulated Medical Products |
| 0910-0697 |
Qualitative Feedback on Food and Drug Administration Service Delivery |
| 0910-0696 |
Followup Study for Infant Feeding Practices Study II |
| 0910-0695 |
Data to Support Drug Product Communications |
| 0910-0694 |
SPF Labeling and Testing Requirements for OTC Sunscreen Products with SPF Values Greater Than 50 |
| 0910-0693 |
Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products |
| 0910-0692 |
Study of Clinical Efficacy Information in Professional Labeling and Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs |
| 0910-0691 |
Experimental Study of Patient Information Prototypes |
| 0910-0690 |
Further Amendments to General Regulations of the Food and Drug Administration to Incorporate Tobacco Products |
| 0910-0689 |
TESTING COMMUNICATIONS ON FDA-REGULATED PRODUCTS USED IN ANIMALS |
| 0910-0688 |
Time and Extent Applications for Nonprescription Drug Products |
| 0910-0687 |
Testing Communications on Biological Products |
| 0910-0686 |
Prescription Drug Advertisements and Product Communications |
| 0910-0685 |
Information Request Regarding Dissolvable Tobacco Products |
| 0910-0684 |
Tobacco Products, Exemptions From Substantial Equivalence Requirements |
| 0910-0683 |
Information Required in Prior Notice of Imported Food |
| 0910-0682 |
Experimental Study of Nutrition Facts Label Formats |
| 0910-0681 |
Recommendations to Reduce the Risk of Transfusion-Transmitted Infection in Whole Blood and Blood Components |
| 0910-0680 |
Tracking Network for PETNet, LivestockNet, and SampleNet |
| 0910-0679 |
Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act |
| 0910-0678 |
Testing Communications On Medical Devices and Radiation-Emitting Products |
| 0910-0677 |
Focus Groups About Drug Products As Used by The Food and Drug Administration |
| 0910-0675 |
Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products |
| 0910-0674 |
Pretesting of Tobacco Communications |
| 0910-0673 |
Reports Intended to Demonstrate the Substantial Equivalence of a New Tobacco Product |
| 0910-0672 |
Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans |
| 0910-0671 |
Warning Plans for Smokeless Tobacco Products |
| 0910-0670 |
GFI: Hypertension Indication; Drug Labeling for Cardiovascular Outcome Claims |
| 0910-0669 |
Abbreviated New Animal Drug Applications |
| 0910-0668 |
Experimental Study of Graphic Cigarette Warning Labels |
| 0910-0667 |
Current Good Manufacturing Practices for Positron Emission Tomography (PET) Drugs |
| 0910-0666 |
Revision of the Requirements for Constituent Material |
| 0910-0665 |
Section 4205 of the Patient Protection and Affordable Care Act Restaurant Menu Labeling; Recordkeeping and Mandatory Third Party Disclosure |
| 0910-0664 |
Section 4205 of the Patient Protection and Affordable Care Act ( P.L. 111-148: Restaurant Menu Labeling : Registration For Small Chains |
| 0910-0663 |
Experimental Study: Presentation of Quantitative Effectiveness Information to Consumers in Direct-to-Consumer (DTC) Television and Print Advertisements for Prescription Drugs |
| 0910-0662 |
Information Request Regarding Menthol in Cigarettes |
| 0910-0661 |
Information to Accompany Humanitarian Device Exemption Applications and Annual Distribution Number Reporting Requirements |
| 0910-0660 |
Production, Storage, and Transportation of Shell Eggs (preventing Salmonella Enteritidis (SE)) |
| 0910-0659 |
Antimicrobial Animal Drug Distribution Reports and Recordkeeping |
| 0910-0658 |
Recordkeeping Requirements for Microbiological Testing and Corrective Measures for Bottled Water |
| 0910-0657 |
Evaluation of Potential Sources for the Sentinel Initiative |
| 0910-0656 |
Gluten-Free Labeling of Food Products Expermental Study |
| 0910-0655 |
Experimental Studies of Nutrition Symbols on Food Packages |
| 0910-0654 |
Tobacco Health Document Submission |
| 0910-0653 |
Expanded Access to Investigational Drugs for Treatment Use |
| 0910-0652 |
Experimental Study: Toll-Free Number for Consumer Reporting of Drug Product Side Effects in Direct-to-Consumer Television Advertisements for Prescription Drugs |
| 0910-0651 |
Charging for Investigation Drugs under an IND |
| 0910-0650 |
Tobacco Product Establishment Registration and Submission of Certain Health Information |
| 0910-0649 |
Mental Models Study of Health Care Providers' Understanding of Prescription Drug Effectiveness |
| 0910-0648 |
PDUFA Pilot Project Proprietary Name Review |
| 0910-0647 |
Tobacco Product Standard on Flavored Cigarettes |
| 0910-0646 |
Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs |
| 0910-0645 |
FDA Adverse Event and Products Experience Reports; Electronic Submissions |
| 0910-0644 |
Survey to Evaluate FDA's Food Defense Awareness Initiative ALERT |
| 0910-0643 |
Reporting and Recordkeeping Requirements for Reportable Food |
| 0910-0642 |
Labeling of Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act |
| 0910-0641 |
Labeling of Nonprescription Human Drug Products Marketed w/o an Approved App as Required by the Dietary Supp & Nonpresription Drug Consumer Protection Act |
| 0910-0639 |
Mental Models Study of Farmers' Understanding and Implementation of Good Agricultural Practices |
| 0910-0638 |
Guidance for Industry on Updating Labeling for Susceptibility Test Information in Systemic Antibacterial Drug Products and Antimicrobial Susceptibility Testing Devices |
| 0910-0637 |
Survey to Evaluate the Effectiveness of Mississippi Delta Fish Advisories |
| 0910-0636 |
Guidance for Industry on Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application |
| 0910-0635 |
Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act |
| 0910-0634 |
Experimental Evaluation of the Impact of Distraction |
| 0910-0633 |
Guidance on Labeling for Natural Rubber Latex Condoms |
| 0910-0632 |
Animal Generic Drug User Fee Cover Sheet |
| 0910-0631 |
Mental Models Study of Communicating with Health Care Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women with Chronic Conditions |
| 0910-0630 |
Requirements for Submission of In Vivo Bioequivalence Data |
| 0910-0629 |
Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics |
| 0910-0628 |
Survey of Current Manufacturing Practices in the Food Industry |
| 0910-0627 |
Cattle Materials Prohibited From Use in Animal Food or Feed |
| 0910-0626 |
Substantiation for Dietary Supplement Claims Made Under Section 403(r)(6) of the Federal Food, Drug, and Cosmetic Act |
| 0910-0625 |
Electronic Submission of Medical Device Registration and Listing |
| 0910-0624 |
Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Pregnancy and Lactation Labeling |
| 0910-0623 |
Reporting and Recordkeeping Requirements for Human Food and Cosmetics Manufactured from, Processed With, or Otherwise Containing, Material from Cattle |
| 0910-0622 |
Foreign Clinical Studies Not Conducted Under an IND |
| 0910-0621 |
Voluntary National Retail Food Regulatory Program Standards |
| 0910-0620 |
Index of Legally Marketed Unapproved New Animal Drugs for Minor Species |
| 0910-0618 |
Mental Models Study of Food Terrorism Risk Awareness |
| 0910-0617 |
Survey of Food Safety and Nutrition Information Provided to Pregnant Women by Health Care Providers and WIC Educators |
| 0910-0616 |
Certification to Accompany Drug, Biological Product, and Device Applications or Submissions |
| 0910-0615 |
FDA Survey of Physicians' Perceptions of the Impact of Early Risk Communication about Medical Products |
| 0910-0614 |
Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile |
| 0910-0613 |
Medical Device User Fee Amendments of 2007; Foreign Small Business Certification Form FDA 3602 A |
| 0910-0612 |
Label Comprehension Study |
| 0910-0611 |
Experimental Evaluation of Variations in Content & Format of the Brief Summery in D-T-C Print Advertisements for Prescription Drugs |
| 0910-0610 |
CGMP for Blood and Blood Components; Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increadsed Risk of Transmitting HCV Infection ("Lookback") |
| 0910-0609 |
Guide to Minimize Food Safety Hazards for Fresh-cut Fruits and Vegetables |
| 0910-0608 |
Petition to Request an Exemption from 100 Percent Identity Testing of Dietary Ingredients: CGMP in Manufacturing, Packaging, Labeling or Holding Operations for Dietary Supplements |
| 0910-0607 |
Administrative Procedures for Clinical Laboratory Improvement Amendments of 1988 Categorization |
| 0910-0606 |
Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements |
| 0910-0605 |
New Animal Drugs for Minor Use and Minor Species |
| 0910-0604 |
Pharmaceutical Development Study |
| 0910-0603 |
Toll-Free Number for Consumer Reporting of Drug Product Side Effects: Comprehension |
| 0910-0602 |
Use of Materials Derived from Cattle in Medical Products Intended for Use in Humans and Drugs Intended for Use in Ruminants |
| 0910-0601 |
Manufactured Food Regulatory Program Standards |
| 0910-0600 |
Supplements and Other Changes to Approved New Animal Drug Applications - Final Rule |
| 0910-0599 |
Cosmetic Labeling and Cosmetic Registration |
| 0910-0598 |
CLIA Waiver Applications |
| 0910-0597 |
Recordkeeping Requirements for Human Food and Cosmetics Manufactured from, Processed With, or Otherwise Containing, Material from Cattle |
| 0910-0596 |
Survey of Need for Online Medical Device Information |
| 0910-0595 |
Authorization of Medical Products for Use Emergencies |
| 0910-0594 |
Guidance for Industry and FDA Staff; Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle |
| 0910-0593 |
MedWatch - The FDA Safety Information and Adverse Event Reporting Program; Proposal to Survey MedWatch Partners Organizations - Survey |
| 0910-0592 |
Experimental Study of Qualified Health Claims: Consumer Inferences About Monounsaturated Fatty Acids from Olive Oil, EPA and DHA Omega-3 Fatty Acids, and Green Tea |
| 0910-0591 |
Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs: Study 1 |
| 0910-0588 |
Survey of Healthcare Practitioners Regarding Their Preferences for Public Health Notifications |
| 0910-0586 |
Medical Devices; Exception from General Requirements for Informed Consent |
| 0910-0585 |
Medical Gas Containers and Closures: Current Good Manufacturing Practice Requirements |
| 0910-0584 |
Guidance for Reagents for Detection of Specific Novel Influenza A Viruses |
| 0910-0583 |
New Plant Varieties Intended for Food Use |
| 0910-0582 |
Guidance on Informed Consent for in Vitro Diagnostic Studies Using Leftover Human Specimens that are not Individually Identifiable |
| 0910-0581 |
Establishment and Operation of Clinical Trial Data Monitoring Committees |
| 0910-0580 |
The Mammography Quality Standards Act Final Regulations: Modifications and Aditions to Policy Guidance Help System #9 |
| 0910-0579 |
Research Study Complaint Form |
| 0910-0578 |
Voluntary Hazard Analysis and Critical Control Point Manuals for Operators and Regulators of Retail and Food Service Establishments |
| 0910-0577 |
Prominent and Conspicuous Mark of Manufacturers on Single-Use Devices |
| 0910-0575 |
Waivers of Invivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form and Type A Medicated Articles |
| 0910-0574 |
Survey on Program Funding |
| 0910-0572 |
Labeling Requirements for Human Prescription Drug and Biological Products |
| 0910-0571 |
Guidance for Requesting an Extension to Use Existing Label Stock After The Trans Fat Labeling Effective Date of January 1, 2006 |
| 0910-0570 |
Experimental Study of Carbohydrate Content Claims on Food Labels |
| 0910-0569 |
Requests for Inspection by an Accredited Person under the Inspection by Accredited Persons Program |
| 0910-0567 |
Allergen Labeling of Food Products Consumer Preference Survey and Experimental Study on Allergen Labeling of Food Products |
| 0910-0566 |
Dispute Resolution Procedures for Science Based Decisions on Products Regulated by the CVM |
| 0910-0565 |
Experimental Study of Health Claims on Food Packages |
| 0910-0564 |
Performance Standard for Diagnostic X-Ray Systems and Their Major Components |
| 0910-0563 |
Formal Dispute Resolution; Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice |
| 0910-0562 |
Channels of Trade Policy for Commodities with Residues of Pesticide Chemicals for Which Tolerances Have Been Revoked, Suspended, or Modified by the EPA |
| 0910-0560 |
Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods |
| 0910-0559 |
Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement |
| 0910-0558 |
Infant Feeding Practices Study II |
| 0910-0557 |
Guidance for Industry - Pharmacogenomic Data Submissions |
| 0910-0555 |
SPresubmission Conferences - Final Rule |
| 0910-0553 |
Use of Symbols on Labels and in Labeling of In Vitro Diagnostic Devices Intended for Professional Use |
| 0910-0551 |
Application for Participation in the Medical Device Fellowship Program; Form FDA 3608 |
| 0910-0549 |
Irradiation in the Production, Processing and Handling of Food |
| 0910-0548 |
Requirements for Collection of Data Relating to Prevention of Medical Gas Mix-ups at Health Care Facilities |
| 0910-0546 |
Reporting Associated with Food Additive Petitions, Investigational Food Additive Files Exemptions, and Declaration of Color Additives on Animal Food Labels |
| 0910-0545 |
Health and Diet Survey |
| 0910-0543 |
Human Cells, Tissues, and Cellular and Tissue-Based Products |
| 0910-0541 |
Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition |
| 0910-0540 |
Animal Drug User Fee Program |
| 0910-0539 |
Animal Drug User Fee Cover Sheet |
| 0910-0538 |
Supplements and Other Changes to an Approved Application - Final Rule |
| 0910-0537 |
Bar Code Label Requirements for Human Drug Products and Biological Products |
| 0910-0533 |
Experimental Study of Trans Fat Claims on Foods |
| 0910-0532 |
Experimental Study of Possible Footnotes and Cueing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosures on the Nutrition Facts Panel (NFP) |
| 0910-0531 |
Experimental Study of Health Claim disclaimers on Foods |
| 0910-0530 |
Requirements for Submission of Labeling for Human Prescription Drugs and Biologics in Electronic Format |
| 0910-0529 |
21 CFR Parts 510 and 558 Requirements for Liquid Medicated Animal Feed and Free-Choice Medicated Animal Feed - NPRM |
| 0910-0528 |
Guidance for Industry - Reports on the Status of Postmarketing Studies - Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997 |
| 0910-0527 |
Certain Biologics Labeling |
| 0910-0524 |
Guidance for Industry: How to Submit a Protocol Without Data in Electronic Format to the Center for Veterinary Medicine |
| 0910-0523 |
Product Jurisdiction and Combination Products |
| 0910-0522 |
Evaluating the Safety of Antimicrobial New Aniam Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern |
| 0910-0521 |
Assessment of the Effects of Antimicrobial Drug Residues from Food of Animal Origin on the Human Intestinal Flora |
| 0910-0520 |
Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 |
| 0910-0519 |
Control of Communicable Diseases; Requests for Exemptions from the Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals |
| 0910-0518 |
Guidance for Industry: Continuous Marketing Applications: Pilot 2 Scientific Feedback and Interactions During Development of Fast Track Products Under PDUFA |
| 0910-0516 |
Impact of Risk Management Programs on the Practice of Pharmacy - Survey |
| 0910-0515 |
Food Labeling: Trans Fatty Acids in Nutrition Labeling |
| 0910-0514 |
Submission of Validation Data for Reprocessed Single-Use Devices |
| 0910-0513 |
Applications for FDA Approval to Market a New Drug: Patent Listing Requirements and Application of 30-month Stays on Approval of Abbreviated New Drug Applications Certifying That... |
| 0910-0511 |
Medical Device User Fee Cover Sheet and Device Facility User Fee Cover Sheet — Form FDA 3601 and Form 3601(a) |
| 0910-0510 |
Inspection by Accredited Persons Program Under the Medical Device User Fee and Modernization Act of 2002 |
| 0910-0509 |
Establishing and Maintaining Lists of U.S.Product Manufacturers/Processors With Interest in Exporting CFSAN-Regulated Products |
| 0910-0508 |
MDUFMA Small Business Qualification Certification |
| 0910-0504 |
Revisions to the General Safety Requirements for Biological Products |
| 0910-0502 |
Registration of Food Facilities |
| 0910-0501 |
Telephone Questionnaire Administration to Control Subjects Recruited into FDA Lyme Vaccine Safety Study, "A Case-Control Study of HLA Type and T-Cell Reactivity to Recombinat Outer..... |
| 0910-0500 |
Rapid Response Surveys |
| 0910-0498 |
Export Certificates for FDA Regulated Products |
| 0910-0497 |
FDA Focus Groups and Interviews |
| 0910-0495 |
Food Additives; Food Contact Substances Notification System |
| 0910-0494 |
The Evaluation of Long-Term Antibiotic Drug Therapy for Persons Involved in Anthrax Remediation Activities |
| 0910-0493 |
Salmonella Discovery System Pilot Study |
| 0910-0492 |
Consumer Surveys on Food and Dietary Supplement Labeling Issues |
| 0910-0491 |
Shortages Data Collection |
| 0910-0489 |
Health and Diet Survey |
| 0910-0486 |
Requirements for States as Certification Agencies |
| 0910-0485 |
Medical Device Labeling Requirements |
| 0910-0484 |
Suggested Documentation for Demonstrating Compliance with Channels of Trade Provision for Foods with Vinclozolin Residues |
| 0910-0483 |
Foreign Establishment Registration and Listing |
| 0910-0482 |
Export Notification and Recordkeeping Requirements |
| 0910-0480 |
Providing Regulatory Submissions in Electronic Format for Food Additive and Color Additive Petitions |
| 0910-0479 |
Assessment of Physician and Patient Attitudes Toward Direct-to-Consumer (DTC) Promotion of Prescription Drugs |
| 0910-0478 |
Consumer and Producer Surveys on Economic Issues |
| 0910-0477 |
Survey of Single-Use Medical Device (SUD) Reuse and Reprocessing in Hospitals |
| 0910-0474 |
General Requirements for Blood, Blood Components, and Blood Derivatives; Donor Notification |
| 0910-0472 |
Requirements for Testing Human Blood Donors for Evidence of Infection Due to Communicate Disease Agents; and Requirements for Donor Notification |
| 0910-0471 |
Adverse Event Program for Medical Devices (Medical Product Safety Network (MedSun)) |
| 0910-0470 |
Special Protocol Assessment (SPA) |
| 0910-0469 |
Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing |
| 0910-0468 |
Focus Group Study of Radiation Disclosure Statement Options |
| 0910-0467 |
Request for Review of Scientific Disputes Concerning the Regulation of Medical Devices |
| 0910-0466 |
Hazard Analysis and Critical Control Point (HACCP) Procedures for the Safe and Sanitary Processing and Importing of Juice |
| 0910-0462 |
Regulations on Statements Made for Dietary Supplements Concerning the Effect of the Product on the Structure or Function of the Body; Stay of Act; Effective Date of Final Rule |
| 0910-0461 |
Substances Approved for Use in the Preparatin of Meat and Poultry Products |
| 0910-0459 |
Information Program on Clinical Trials for Serious and Life-Threatening Diseases: Maintaining a Databank |
| 0910-0458 |
Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing |
| 0910-0457 |
Rapid Response Surveys |
| 0910-0456 |
PHS Guideline on Infectious Disease Issues in Xenotransplantation |
| 0910-0455 |
Documentation for demonstrating compliance with the Channels |
| 0910-0454 |
Guidance for Industry on How to Submit Information in Electronic Format to the Center for Veterinary Medicine Using the FDA Electronic Submission Gateway |
| 0910-0453 |
Guidance for Industry on How to Use E-Mail to Submit a Notice of Final Disposition of Invest. Animals Not Intended for Immediate Slaughter |
| 0910-0452 |
Guidance for Indusry on How to Use E-Mail to Submit a Request for a Meeting or Teleconference in Electronic Format to the Center for Veterinary Medicine |
| 0910-0450 |
Guidance for Industry on How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes in Electronic Format to CVM |
| 0910-0449 |
Postmarket Surveillance of Medical Devices |
| 0910-0448 |
Adoption of FDA Food Code by Local, State and Tribal Governments |
| 0910-0446 |
Survey of Incidence of gastroenterological Parasitic Infections |
| 0910-0445 |
Guidance for Industry: Submitting and Reviewing Complete Responses to Clinical Holds |
| 0910-0444 |
Food additives; Food Contact Substances Notification System |
| 0910-0443 |
Survey of Incidence of Gastroenterolocial Parasitic Infections in the United States as a Result of Consumption of Raw Fish |
| 0910-0442 |
Medical Devices; Device Tracking |
| 0910-0439 |
Aluminum in Large and Small Volume Parenterals Used in Total Parenteral Nutrition |
| 0910-0437 |
Medical Device Reporting |
| 0910-0435 |
Prescription Drug Marketing: Administrative Procedures, Policies, and Requirements |
| 0910-0433 |
Postmarketing Studies for Human Drugs and Licensed Biological Products; Status Report |
| 0910-0432 |
Medical Device Recall Authority |
| 0910-0431 |
Changes to an Approved NDA or ANDA |
| 0910-0430 |
Formal Dispute Resolutions; Appeals Above the Division Level |
| 0910-0429 |
Formal Meetings with Sponsors and Applicants for PDUFA Products |
| 0910-0428 |
Record Retention Requirements for the Soy Protein/CHD Health Claim |
| 0910-0427 |
Biological Product Regulated under Section 351 of the Public Health Service Act; Implementation of Biologics License; Elimination of Establishment License and Product License |
| 0910-0426 |
Quality Mammography Standards: Lay Summaries for Patients |
| 0910-0425 |
Survey of Food Manufacturers for Year 2000 Compliance |
| 0910-0423 |
New Drug and Biological Drug Products; Evidence Needed to Demonstrate Efficacy of New Drugs for Use Against Lethal Or Permanently Disabling Toxic Substances When Efficacy Studies.... |
| 0910-0422 |
Survey of Manufacturing Practices in the Dietary Supplement Industry |
| 0910-0417 |
Survey of Biomedical Equipment Manufacturers for Year 2000 Compliance |
| 0910-0416 |
Investigational New Drug Applications and New Drug Applications |
| 0910-0411 |
Study of Manufacturers of Computer-Controlled, Potentially High-Risk Medical Devices Regarding Year 2000 Status |
| 0910-0409 |
Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring |
| 0910-0408 |
Survey of Licensed Biologics Manufacturers and Registered Blood Establishments for Year 2000 Compliance |
| 0910-0405 |
Survey of Medical Device Manufacturers for Year 2000 Compliance of Manufacturing Processes |
| 0910-0402 |
Survey of Drug Manufacturers, Distributors, Repackagers, and Other Drug Distribution Facilities for Year 2000 Compliance |
| 0910-0399 |
Attitudinal and Behavioral Effects of Direct-to-Consumer (DTC) Advertising of Prescription Drugs (Survey) |
| 0910-0398 |
Labeling for Menstrual Tampons; Absorbency Range of 15-18 Grams |
| 0910-0397 |
Survey of Biomedical Equipment Manufacturers for Year 2000 Compliant Products |
| 0910-0396 |
Financial Disclosure by Clinical Investigators |
| 0910-0395 |
Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis |
| 0910-0393 |
Prescription Drug Product Labeling; Medication Guide Requirements |
| 0910-0392 |
Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients |
| 0910-0391 |
Investigational Device Exemptions, Modifications |
| 0910-0390 |
Dissemination of Information on Unapproval/New Uses for Marketed Drugs, Biologics, and Devices |
| 0910-0389 |
Guidance for Industry: Fast Track Drug Development Programs - Designation, Development, and Application Review |
| 0910-0388 |
Guidance for Industry: Current Good Manufacturing Practice for Blood and Blood Components: (1) Quarantine and Disposition of Units from Prior Collections from Donors with Repeatedly.... |
| 0910-0387 |
Medical Devices Registration and Listing |
| 0910-0385 |
Supplements to Premarket Approval Applications for Medical Devices |
| 0910-0384 |
Medical Devices: Humanitarian Use Devices |
| 0910-0383 |
Access to Mammography Services Survey |
| 0910-0381 |
Food Labeling Regulations |
| 0910-0378 |
Medical Devices, Third Party Premarket Submission Review and Quality System Inspections Under U.S./E.C. MRA |
| 0910-0376 |
Transmittal of Advertising and Promotional Labeling for Drugs and Biologics for Human Use |
| 0910-0375 |
510(k) Third-Party Review Program |
| 0910-0374 |
Guidance for Industry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body |
| 0910-0372 |
Manufacturers of Human Cellular and Tissue-Based Products |
| 0910-0370 |
Specific Requirements on the Content and Format of Labeling for Human Prescription Drugs; Addition of Geriatric Use Subsection |
| 0910-0369 |
Tobacco Retailer Tracker Study |
| 0910-0368 |
OTC Test Sample Collection Systems for Drugs of Abuse Testing - 21 CFR Part 809 |
| 0910-0367 |
Performance Standard for Electrode Lead Wires and Patient |
| 0910-0366 |
Financial Disclosure by Clinical Investigators -- 21 CFR Part 54 |
| 0910-0365 |
Serving Sizes: Reference Amount for Candies |
| 0910-0364 |
Nutrition Labeline: Declaration of Caloric Amounts and Serving Sizes for Breath Mints |
| 0910-0363 |
Veterinary Feed Directive |
| 0910-0362 |
Serving Sizes: Reference Amount for Salt, Salt Substitutes, |
| 0910-0361 |
Classification/reclassification; Restricted Devices; Analyte Specific Reagents |
| 0910-0360 |
Customer/Partner Satisfaction Service Surveys |
| 0910-0359 |
Medical Devices; Reports of Corrections and Removals |
| 0910-0358 |
Tobacco Retailer Tracking Study |
| 0910-0357 |
Serving Sizes: Reference Amount for Baking Powder, Baking Soda, and Pectin |
| 0910-0356 |
Substantial Evidence of Effectiveness of New Animal Drugs |
| 0910-0355 |
Survey of Food Safety Practices of Food Processing Firms |
| 0910-0354 |
Procedures for the Safe Processing and Importing of Fish and Fishery Products |
| 0910-0353 |
Sterility Requirement for Aqueous-Based Drug Products for Oral Inhalation; final rule |
| 0910-0352 |
Latex Condoms; User Labeling - Expiration Dating (21 CFR 801.435) |
| 0910-0351 |
Food Labeling: Statement of Identity, Nutrition Labeling, |
| 0910-0349 |
Nutrient Content Claims and Health Claims, Restaurant Foods |
| 0910-0348 |
Medical Devices, Investigational Device Exemptions, Treatment |
| 0910-0345 |
Food Safety, Health, and Diet Survey |
| 0910-0343 |
Evaluation of Revised Formats for Over-the-Counter (OTC) Drugs |
| 0910-0342 |
Substances Generally Recognized as Safe: Notification Procedure |
| 0910-0341 |
FDA Safety Communication Readership Survey |
| 0910-0340 |
General Drug Labeling Provisions and OTC Monograph Drug User Fee Submissions |
| 0910-0339 |
Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed |
| 0910-0338 |
Biologics License Applications; Procedures & Requirements |
| 0910-0337 |
Medicated Feed Mill License Application |
| 0910-0336 |
Current Good Manufacturing Practices for Blood and Blood Components; Notification of Consignees Receiving Blood and Blood Components at Increased Risk for Transmitting HIV |
| 0910-0335 |
Gender Differences in Perception of Risks Communicated by Prescription and Over-the-Counter Drug Labels, Survey |
| 0910-0334 |
Notification of Nutrient Content Claims for Fat or Fatty Acids |
| 0910-0332 |
Medical Devices; Humanitarian Use Devices |
| 0910-0331 |
Food Labeling: Notification Procedures for Statements on Dietary Supplements |
| 0910-0330 |
Premarket Notification for a New Dietary Ingredient |
| 0910-0325 |
Extralabel Drug Use in Animals |
| 0910-0324 |
Small Business Exemption Notices -- 21 CFR Part 101 |
| 0910-0323 |
Current Good Manufacturing Practice, Proposed Amendment of |
| 0910-0322 |
Environmental Impact Considerations |
| 0910-0320 |
Request for Information from U.S. Processors that Export to the European Community |
| 0910-0318 |
Medical Devices; Third-Party Review of Selected Premarket Notifications; Pilot Program |
| 0910-0317 |
Permanent Listing of Color Additive Lakes |
| 0910-0316 |
Well-Characterized Biotechnology Products, Elimination of |
| 0910-0315 |
General Licensing Provisions: Changes to an Approved Application; Labeling; and Revocation and Suspension |
| 0910-0312 |
Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect Children and Adolescents |
| 0910-0311 |
Use of Auditory Canal Thermometers in Pediatric and Family practice Offices. |
| 0910-0310 |
Joint FDA/NHLBI Health and Diet Survey, Cycle VI |
| 0910-0309 |
Mammography Standards Quality Act Requirements |
| 0910-0308 |
Biological Products; General records and postmarket adverse experience reporting |
| 0910-0306 |
Pesticide Residue Study of Monthly Rice Production Volumes from Operating U.S. Rice Mills |
| 0910-0305 |
Abbreviated New Drug Application Regulations; Patent and Exclusivity Provisions |
| 0910-0303 |
Electronic Records: Electronic Signatures |
| 0910-0302 |
Human Tissue Intended for Transplantation |
| 0910-0301 |
TISSUE BANK SURVEY |
| 0910-0300 |
FOOD LABEL USE AND NUTRITION EDUCATION SURVEY |
| 0910-0299 |
INVESTIGATIONAL DEVICE EXEMPTIONS, DISQUALIFICATION OF CLINICAL INVESTIGATORS (PROPOSED RULE) |
| 0910-0298 |
Threshold of Regulation for Substances Used in Food-Contact Articles |
| 0910-0297 |
Prescription Drug User Fee Program |
| 0910-0296 |
MEDICAL DEVICE INNOVATION SURVEY |
| 0910-0293 |
MEDICAL DEVICE RECALL COST SURVEY |
| 0910-0291 |
MedWatch: Adverse Event and Product Experience Reporting System (Paper-Based) |
| 0910-0290 |
NATIONAL SURVEY OF PHYSICIANS CONCERNING PERCEPTIONS OF DRUG PRODUCT LABELING AND THE BRIEF SUMMARY |
| 0910-0289 |
NEW ANIMAL DRUG REGULATIONS -- 21 CFR PART 514 (PROPOSED RULE) |
| 0910-0288 |
FOOD LABELING: NUTRIENT CONTENT CLAIMS, GENERAL PRINCIPLES, PETITIONS, DEFINITION OF TERMS, DEFINITIONS OF NUTRIENT CONTENT CLAIMS FOR THE FATTY ACID & CHOLESTEROL CONTENT, ETC |
| 0910-0287 |
FOOD LABELING: GENERAL REQUIREMENTS FOR HEALTH CLAIMS FOR FOOD -- 21 CFR PART 101 |
| 0910-0286 |
Reference Amount Petitions -- 21 CFR 100.12(h) |
| 0910-0284 |
Adverse Experience/Events with Approved New Animal Drugs |
| 0910-0282 |
INFANT FEEDING PRACTICES SURVEY |
| 0910-0281 |
Medical Devices: Substantial Equivalence, 510(k) Summaries |
| 0910-0280 |
CONSUMER FOOD HANDLING PRACTICES AND AWARENESS OF MICROBIOLOGICAL HAZARDS |
| 0910-0279 |
Year 2004 Updates on the National Survey of Prescription Drug Information Provided to Patients |
| 0910-0277 |
State Petitions for Exemption from Preemption |
| 0910-0275 |
State Enforcement Notifications |
| 0910-0271 |
STUDY OF FOOD LABEL FORMATS: PHASE II |
| 0910-0268 |
STUDY OF FOOD LABEL FORMATS - MAIN STUDY |
| 0910-0267 |
WEIGHT LOSS PRACTICES SURVEY |
| 0910-0266 |
JOINT FDA/NHLBI HEALTH AND DIET SURVEY, CYCLE V |
| 0910-0265 |
FOOD LABELING COST SURVEY |
| 0910-0264 |
Export of Medical Devices ; Foreign Letters of Approval |
| 0910-0263 |
READERSHIP EVALUATION OF THE FDA DRUG BULLETIN |
| 0910-0262 |
CONSUMER SURVEY OF COSMETIC USAGE PATTERNS FOR RISK ASSESSMENT |
| 0910-0261 |
AUTOMATIC DETENTION AND PRIVATE LABORATORY TESTING OF FDA-REGULATED PRODUCTS FOR IMPORT ENTRY |
| 0910-0260 |
TREATMENT OF NARCOTIC ADDICTS, JOINT REVISION OF CONDITIONS FOR USE, INTERIM MAINTENANCE TREATMENT -- 21 CFR PART 291 |
| 0910-0259 |
TEA CHOP LIST AND APPELLANT'S APPLICATION FOR REVIEW OF EXAMINER'S RETURN |
| 0910-0258 |
APPLICATION FOR AUTHORIZATION TO RELABEL OR TO PERFORM OTHER ACTIONS |
| 0910-0257 |
LABELING FOR MENSTRUAL TAMPONS - RANGES OF ABSORBENCY 21 CFR 801.430(E),(F) |
| 0910-0256 |
Infant Formula Requirements |
| 0910-0255 |
INTERNAL ANALGESIC, ANTIPYRETIC, ANTIRHEUMATIC DRUG PRODUCTS FOR OTC HUMAN USE - NPRM |
| 0910-0254 |
LABEL DECLARATIONS: CHOLESTEROL CONTENT OF FOODS (NPRM) |
| 0910-0253 |
MEDICAL DEVICE CONFORMANCE ASSESSMENT TO VOLUNTARY STANDARDS |
| 0910-0251 |
Guidelines for State Licensing of Wholesale Drug Distributors |
| 0910-0250 |
LABELING REQUIREMENTS FOR SULFITING AGENTS IN STANDARDIZED FOODS - NPRM 21 CFR 130 |
| 0910-0249 |
FDA Recall Regulations |
| 0910-0248 |
SURVEY OF JAPANESE PHARMACEUTICAL FIRMS REGARDING NEW BIOTECHNOLOGY PRODUCTS |
| 0910-0247 |
HUMAN FACTORS REGARDING THE USE OF GLUCOSE MONITORING EQUIPMENT |
| 0910-0245 |
SURVEY OF CONSUMER FOOD-HANDLING PRACTICES AND AWARENESS OF MICROBIOLOGICAL HAZARDS |
| 0910-0242 |
Aspartame as an Inactive Ingredient in Human Drug Products, Labeling Requirements |
| 0910-0241 |
SURVEY TO DETERMINE PATIENT KNOWLEDGE AND PERCEPTIONS ON HEMODIALYSIS REUSE |
| 0910-0240 |
JOINT FDA/NHLBI/NCI HEALTH AND DIET SURVEY, CYCLE IV |
| 0910-0238 |
DECLARATION OF NET QUANTITY |
| 0910-0237 |
BRONCHODILATOR DRUG PRODUCTS FOR OTC HUMAN USE |
| 0910-0235 |
Foreign Language Disclosure Labeling |
| 0910-0234 |
CARDIAC PACEMAKER REGISTRY |
| 0910-0233 |
Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions |
| 0910-0232 |
Antheimintic Drug Products for OTC Human Use |
| 0910-0231 |
Premarket Approval of Medical Devices |
| 0910-0230 |
Postmarketing Adverse Drug Experience Reporting |
| 0910-0229 |
APPROVAL OF BULK NEW ANIMAL DRUG SUBSTANCES FOR USE BY LICENSED VETERINARIANS - NPRM |
| 0910-0228 |
SPONSORED COMPOUNDS IN FOOD-PRODUCING ANIMALS, CRITERIA AND PROCEDURES FOR EVALUATING THE SAFETY OF CARCINOGENIC RESIDUES |
| 0910-0227 |
TEST FOR ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS (HIV) -- 21 CFR 640 |
| 0910-0226 |
INTERNATIONAL DRUG SCHEDULING, CONVENTION ON PSYCHOTROPIC SUBSTANCES, NON-BARBITURATE SEDATIVES - VOLUNTARY SUBMISSION OF DATA AND COMMENTS ON THE ABUSE POTENTIAL, ACTUAL ABUSE... |
| 0910-0225 |
EXOCRINE PANCREATIC INSUFFICIENCY DRUG PRODUCTS FOR OTC HUMAN USE - NPRM |
| 0910-0224 |
CHOLESTEROL, FAT AND FATTY ACIDS LABELING, 21 CFR PART 101 |
| 0910-0223 |
21 CFR 101.3(E)(1) AND 21 CFR 101.3(E)(2) - IDENTIFY LABELING OF FOOD IN PACKAGE FORM - 21 CFR 101.3 |
| 0910-0222 |
COMMON OR USUAL NAME: LABELING OF PEANUT SPREADS (21 CFR PART 102) |
| 0910-0221 |
FOLLOW UP OF GROWTH HORMONE RECIPIENTS |
| 0910-0220 |
INFANT FEEDING PRACTICES STUDY |
| 0910-0219 |
Medical Devices Standards Activities Report |
| 0910-0218 |
LABELING OF WEIGHT CONTROL FOODS |
| 0910-0216 |
Color Additive Certification |
| 0910-0215 |
QUICK TURNAROUND RESEARCH SERVICES - FDA 1986 MULTIPURPOSE SURVEY |
| 0910-0213 |
Recordkeeping for Electronic Products, Specific Product |
| 0910-0212 |
Regulations Under the Federal Import Milk Act |
| 0910-0211 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF HUMAN T-LYMPHOTROPIC VIRUS FOR IN-VITRO DIAGNOSTIC USE |
| 0910-0210 |
PROPOSED RULE - ADVERSE DRUG EXPERIENCE REPORTING REQUIREMENTS FOR MARKETED PRESCRIPTION DRUGS WITHOUT APPROVED NEW DRUG OR ABBREVIATED NEW DRUG APPLICATIONS |
| 0910-0209 |
ADDITIONAL STANDARDS FOR DIAGNOSTIC SUBSTANCES FOR LABORATORY TESTS, PROPOSED AMENDMENTS OF REQUIREMENTS FOR BLOOD GROUPING SERUM-NPRM |
| 0910-0208 |
ADDITIONAL STANDARDS FOR ANTI-HUMAN GLOBULIN - 21 CFR 660 SUBPART F |
| 0910-0207 |
LAXATIVE DRUG PRODUCTS FOR OTC HUMAN USE - NPRM |
| 0910-0206 |
Request for Samples and Protocols |
| 0910-0205 |
NEW ANIMAL DRUG REQUIREMENTS FOR MEDICATED FREE-CHOICE FEEDS 21 CFR 510.455 |
| 0910-0204 |
EXPORT OF INVESTIGATIONAL NEW ANIMAL DRUGS, TENTATIVE FINAL RULE |
| 0910-0203 |
GOOD LABORATORY PRACTICE REGULATIONS FOR NONCLINICAL LABORATORY STUDIES |
| 0910-0201 |
MEDICAL DEVICE REPORTING |
| 0910-0200 |
LABELING - FOODS AND COSMETICS |
| 0910-0198 |
FOOD LABELING: DECLARATION OF SODIUM CONTENT OF FOODS AND LABEL CLAIMS FOR FOODS ON THE BASIS OF SODIUM CONTENT 21 CFR PART 101 |
| 0910-0197 |
"REQUEST FOR EXTENSION OF COMMENT PERIOD" |
| 0910-0196 |
GENERAL STANDARD OF IDENTITY FOR "CERTAIN OTHER CHEESES', NPRM, 21 CFR PART 133 |
| 0910-0195 |
LABELING REQUIREMENTS FOR MEDICAL DEVICES AND RADIOLOGICAL PRODUCTS |
| 0910-0194 |
Petition for Administrative Stay of Action - 21 CFR 10.35 |
| 0910-0193 |
Advisory Opinions |
| 0910-0192 |
Petition for Administrative Reconsideration of Action - 21 CFR 10.33 |
| 0910-0191 |
Administrative Practices and Procedures; Formal Hearings |
| 0910-0190 |
NATIONAL ENVIRONMENTAL POLICY ACT: POLICIES AND PROCEDURES -- 21 CFR PART 25 |
| 0910-0188 |
Infant Formula Recall Regulations |
| 0910-0187 |
LABELING REQUIREMENTS FOR HUMAN DRUGS, BIOLOGICS AND VETERINARY DRUGS |
| 0910-0186 |
Irradiation in the Production, Processing and Handling of Food |
| 0910-0185 |
Labeling Requirements for Color Additives (other than hair dyes) and Petitions |
| 0910-0184 |
Filing Objections and Requests for a Hearing on a Regulation or Order |
| 0910-0183 |
General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions |
| 0910-0182 |
Use of Impact Resistant Lenses in Eyeglasses and Sunglasses OMB No. 0910-0182 |
| 0910-0181 |
REQUEST FOR CERTIFICATION OF AN INSULIN BATCH |
| 0910-0179 |
INFANT FORMULA QUALITY CONTROL AND LABELING |
| 0910-0178 |
FOOD AND DRUG ADMINISTRATION FY '84 CONSUMER FOOD SURVEY |
| 0910-0177 |
NUTRITION LABELING, 21 CFR 101.9 (B) & (C) |
| 0910-0176 |
AMENDMENTS TO PERFORMANCE STANDARD FOR LASER PRODUCTS |
| 0910-0171 |
Hearing Aid Devices: Professional and Patient Labeling and Conditions for Sale |
| 0910-0168 |
Shipment of a Blood Product Prior to Completion of Testing for Products Known Reactive for HBsAg |
| 0910-0167 |
Orphan Drugs |
| 0910-0164 |
PRESCRIPTION DRUG ADVERTISING TO CONSUMERS STUDY |
| 0910-0163 |
MEDICATED FEED APPLICATION - NPRM |
| 0910-0162 |
INVESTIGATIONAL NEW DRUG APPLICATION |
| 0910-0161 |
ALLERGENIC PRODUCTS, LIST OF SOURCE MATERIALS |
| 0910-0159 |
INFANT FORMULA, LABELING REQUIREMENTS |
| 0910-0158 |
EXEMPT INFANT FORMULA |
| 0910-0155 |
REPORTING REQUIREMENTS APPLICABLE TO NORMAL SERUM ALBUMIN AND PLASMA PROTEIN FRACTION |
| 0910-0154 |
Good Manufacturing Practice Regulations for Type A Medicated Articles |
| 0910-0152 |
Current Good Manufacturing Practice Regulations for Medicated Feed |
| 0910-0151 |
TEMPORARY EXEMPTIONS FROM CERTAIN FOOD LABELING REQUIREMENTS FOR PURPOSE OF CONDUCTING AUTHORIZED FOOD LABELING EXPERIMENTS -- 21 CFR 101.108(B) |
| 0910-0150 |
TAMPER RESISTANT PACKAGING REQUIREMENTS FOR CONTACT LENS SOLUTIONS AND TABLETS |
| 0910-0149 |
Tamper-Resistant Packaging Requirements for OTC Human Drug Products |
| 0910-0148 |
FORMALDEHYDE CLEARINGHOUSE DATA FORM |
| 0910-0147 |
FDA FY '82 CONSUMER SURVEY |
| 0910-0145 |
QUANTITY AND NATURE OF PATIENT INTERACTIONS WITH PHYSICIANS AND PHARMACISTS RE: PRESCRIPTIONS |
| 0910-0144 |
STATE AGENCY OPINION SURVEY |
| 0910-0143 |
MEDICAL DEVICE AND LABORATORY PRODUCT PROBLEM REPORTING PROGRAM |
| 0910-0141 |
PHYSICIAN RESPONSE TO REDUCED INFORMATION REQUIREMENTS IN PRESCRIPTION DRUG ADVERTISING |
| 0910-0140 |
Conditions for the Use of Narcotic Drugs for Treatment of Narcotic Addiction, Reporting and Recordkeeping Requirements |
| 0910-0139 |
Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Medical Gases and Active Pharmaceutical Ingredients) |
| 0910-0138 |
Reclassification Petitions for Medical Devices |
| 0910-0137 |
REPORTING REQUIREMENTS APPLICABLE TO THE MANUFACTURE OF BLOOD GROUPING SERUM |
| 0910-0136 |
HEPATITIS REPORTING REQUIREMENTS - 21 CFR 610 |
| 0910-0135 |
RECORDKEEPING REQUIREMENTS FOR EXEMPTION FROM FDA APPROVAL FOR NEW DRUGS USED IN NONHUMAN RESEARCH |
| 0910-0134 |
REPORTING AND RECORDKEEPING REQUIREMENTS APPLICABLE TO THE EXEMPTIONS FROM ANTIBIOTIC CERTIFICATION AND LABELING PROGRAM |
| 0910-0133 |
Temporary Marketing Permit Applications |
| 0910-0132 |
Affirmation of Generally Recognized as Safe GRAS Status |
| 0910-0131 |
Agreement for Shipments of Devices for Sterilization |
| 0910-0130 |
Protection of Human Subjects and Institutional Review Boards |
| 0910-0129 |
Applications for Exemption From Federal Preemption of State and Local Medical Device Requirements - 21 CFR Part 808 |
| 0910-0128 |
MEASURING TIMELINESS AND RESPONSIVENESS OF LETTERS TO CONSUMERS |
| 0910-0127 |
NATIONAL CONSUMER AWARENESS AND ACCESS PROJECT EVALUATION |
| 0910-0126 |
SURVEY OF SMALL MANUFACTURERS (REGULATORY FLEXIBILITY) |
| 0910-0124 |
Establishment and Product License Applications |
| 0910-0120 |
Premarket Notification Submission 510(k), Subpart E |
| 0910-0119 |
Good Laboratory Practice (GLP) Regulations for Nonclinical Laboratory Studies |
| 0910-0117 |
New Animal Drugs for Investigational Use |
| 0910-0116 |
Current Good Manufacturing Practices for Blood and Related Regulations for and Blood Components; and Requirements for Donor Testing, Donor Notification, and "Lookback" |
| 0910-0115 |
BUREAU OF MEDICAL DEVICES STANDARDS SURVEY |
| 0910-0114 |
Administrative Detention and Banned Medical Devices |
| 0910-0112 |
FY '80 MULTI-PURPOSE FOOD SURVEY |
| 0910-0111 |
PHYSICIAN INTERPRETATION OF RESEARCH DATA |
| 0910-0110 |
POISON CONTROL QUESTIONNAIRE - PART I |
| 0910-0106 |
NATIONAL SURVEY OF CHEST X-RAY SCREENING POLICIES |
| 0910-0105 |
CONSUMER COMPREHENSION OF OTC DRUG LABELING |
| 0910-0101 |
COMPUTED TOMOGRAPHY USE AND QUALITY ASSURANCE SURVEY |
| 0910-0098 |
NUCLEAR MEDICINE QUALITY ASSURANCE PROJECT |
| 0910-0097 |
SURVEY OF NUTRITION VOCABULARY AND QUANTITATIVE DECLARATIONS |
| 0910-0096 |
SPECIAL DIETARY FOODS SURVEY |
| 0910-0091 |
EFFECT OF PPI'S AS A FUNCTION OF CRITICAL VARIATIONS |
| 0910-0083 |
NEXT IMAGE RECEPTOR MODULE |
| 0910-0081 |
A FOLLOW-UP STUDY OF PERSONS WHO HAD 131 IODINE AND OTHER THYROID TESTS |
| 0910-0079 |
SOURCE PLASMA (HUMAN) AMENDMEND TO STORAGE TEMPERATURE REQUIREMENTS |
| 0910-0078 |
Investigational Device Exemptions |
| 0910-0077 |
PRODUCT APPLICATION FOR THE MANUFACTURE OF WHOLE BLOOD AND BLOOD COMPONENTS |
| 0910-0076 |
MEDICATED FEED APPLICATION FDA-1900 |
| 0910-0075 |
OBLIGATIONS OF SPONSORS AND MONITORS OF CLINICAL INVESTIGATIONS |
| 0910-0074 |
COLOR ADDITIVE PETITION |
| 0910-0073 |
Medical Devices; Quality System Regulation Amendments: FINAL RULE |
| 0910-0072 |
PERFORMANCE STANDARDS DEVELOPMENT |
| 0910-0071 |
RADIATION INCIDENTS REGISTRY REPORTING PROGRAM |
| 0910-0070 |
REIMBURSEMENT FOR PARTICIPATION IN ADMINISTRATIVE PROCEEDINGS |
| 0910-0069 |
RADIATION EXPERIENCE DATA STUDY |
| 0910-0068 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURER OF SINGLE DONOR PLASMA |
| 0910-0067 |
INTRAOCULAR LENS INVESTIGATIONAL DEVICE EXEMPTION APPLICATION |
| 0910-0066 |
INVESTIGATIONAL SHIPMENT OF IN VITRO DIAGNOSTIC DEVICES |
| 0910-0065 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF ANTI-HUMAN GLOBULIN SERA |
| 0910-0064 |
HIGH-YIELD CRITERIA FORM |
| 0910-0063 |
USER EXPERIENCES WITH EXTENDED-WEAR AND OTHER TYPES OF CONTACT LENSES |
| 0910-0062 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF REAGENT RED BLOOD CELLS |
| 0910-0061 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF BLOOD GROUPING SERA |
| 0910-0060 |
MEDICAL DEVICE REGISTRATION |
| 0910-0059 |
Medical Devices: Medical Device Reporting, Certification |
| 0910-0058 |
BLOOD SAMPLE IDENTIFICATION CARD |
| 0910-0057 |
MEDICAL DEVICE LISTING |
| 0910-0055 |
NEW DRUG AND ANTIBIOTIC REGULATIONS |
| 0910-0054 |
ASHP/FDA DRUG SHORTAGE MONITORING PROGRAM |
| 0910-0053 |
Radioactive Drug Research Committees |
| 0910-0052 |
Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices |
| 0910-0051 |
DECLARATION FOR PRODUCTS SUBJECT TO RADIATION CONTROL STANDARDS |
| 0910-0050 |
NATIONAL/REGIONAL/STATE TELECOMMUNICATIONS NETWORK TRAFFIC LOG |
| 0910-0049 |
ANNUAL REVIEW OF STATE AND LOCAL RADIOLOGICAL HEALTH PROGRAMS |
| 0910-0048 |
Notice of Availability of Sample Electronic Product |
| 0910-0047 |
COSMETIC PRODUCT EXPERIENCE REPORTS -- 21 CFR PART 730 |
| 0910-0046 |
Imports and Electronic Import Entries |
| 0910-0045 |
Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution |
| 0910-0044 |
HOSPITAL REQUEST FOR METHADONE FOR DETOXIFICATION AND TEMPORARY MAINTENANCE TREATMENT |
| 0910-0043 |
APPLICATION FOR APPROVAL OF USE OF METHADONE IN A TREATMENT PROGRAM |
| 0910-0042 |
MEDICAL RESPONSIBILITY STATEMENT FOR USE OF METHADONE IN A TREATMENT PROGRAM |
| 0910-0041 |
ESTABLISHMENT LICENSE APPLICATION AND SUPPLEMENTAL LICENSE APPLICATION FOR THE MANUFACTURE OF BLOOD AND BLOOD COMPONENTS |
| 0910-0040 |
PRODUCT LICENSE APPLICATION FOR THE MANUFACTURE OF SOURCE PLASMA |
| 0910-0039 |
Transmittal of Labels and Circulars |
| 0910-0038 |
CONFERENCE OF RADIATION CONTROL PROGRAM DIRECTORS NEXT SURVEY |
| 0910-0037 |
Food Canning Establishment Registration, Process Filing and Recordkeeping for Acidified and Thermally Processed Low-Acid Foods |
| 0910-0036 |
REGULATORY REQUIREMENTS FOR LOW-ACID AND ACIDIFIED CANNED FOOD PROCESSORS, 21 CFR PARTS 108, 113, AND 114 |
| 0910-0035 |
FOOD CANNING AND PROCESS FILING FOR OTHER THAN STILL RETORT AND AGITATING PROCESSES |
| 0910-0034 |
FOOD CANNING ESTABLISHMENT AND PROCESS FILING FOR AGITATING PROCESSES |
| 0910-0033 |
FOOD CANNING ESTABLISHMENT AND PROCESS FILING FOR STILL RETO RT PROCESSES |
| 0910-0032 |
Reporting Associated with New Animal Drug Applications and Veterinary Master Files |
| 0910-0031 |
COSMETIC RAW MATERIAL COMPOSITION STATEMENT |
| 0910-0030 |
Cosmetic Product Voluntary Reporting Program |
| 0910-0029 |
NOTICE OF DISCONTINUANCE OF COMMERCIAL DISTRIBUTION OF COSMETIC PRODUCT OR COSMETIC RAW MATERIAL |
| 0910-0028 |
REPORT OF ASSEMBLY OF A DIAGNOSTIC X-RAY SYSTEM |
| 0910-0027 |
Voluntary Cosmetic Registration Program |
| 0910-0026 |
DRUG EXPERIENCE REPORT (SHORT FORM) |
| 0910-0025 |
Electronic Products Requirements |
| 0910-0024 |
DRUG QUALITY REPORTING SYSTEM |
| 0910-0023 |
POISONING REPORT |
| 0910-0022 |
SHELLFISH CERTIFICATION CANCELLATION |
| 0910-0021 |
Interstate Shellfish Dealer's Certificate |
| 0910-0020 |
RESOURCE DATA FOR STATE FOOD AND DRUG PROGRAMS |
| 0910-0019 |
TRANSMITTAL OF PERIODIC REPORTS AND PROMOTIONAL MATERIAL FOR NEW ANIMAL DRUGS -- 21 CFR PART 510 |
| 0910-0018 |
TRANSMITTAL OF ADVERTISEMENTS AND PROMOTIONAL LABELING FOR HUMAN USE |
| 0910-0017 |
TRANSMITTAL OF PERIODIC REPORTS FOR DRUGS FOR HUMAN USE |
| 0910-0016 |
Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions, and Electronic Submission Using FDA Form 3503 |
| 0910-0015 |
STATEMENT OF INVESTIGATOR (CLINICAL PHARMACOLOGY) |
| 0910-0014 |
Investigational New Drug Regulations |
| 0910-0013 |
STATEMENT OF INVESTIGATOR |
| 0910-0012 |
Veterinary Adverse Drug Reaction, Lack of Effectivenesss, Product Defect Report, and Transmittal of Periodic Reports and Promotional Material for New Animl Drugs, 21 CFR Part 510 |
| 0910-0011 |
Medicated Feed Application |
| 0910-0010 |
APPLICATION FOR COMMISSION |
| 0910-0009 |
REQUEST FOR SUPPLEMENTAL CERTIFICATION OF A BATCH OF ANTIBIOTIC DRUGS |
| 0910-0008 |
APPLICATION FOR EXEMPTION FOR REPACKING OF ANTIBIOTICS |
| 0910-0007 |
REQUEST FOR CERTIFICATION OR TESTING OF AN ANTIBIOTIC BATCH |
| 0910-0006 |
APPLICATION FOR EXEMPTION FOR MANUFACTURING USE OF ANTIBIOTICS |
| 0910-0005 |
APPLICATION FOR EXEMPTION FOR LABELING OF ANTIBIOTIC DRUGS |
| 0910-0004 |
APPLICATION FOR EXEMPTION FOR PROCESSING OF ANTIBIOTIC DRUGS |
| 0910-0003 |
APPLICATION FOR EXEMPTION FOR STORAGE OF ANTIBIOTIC DRUGS |
| 0910-0002 |
DRUG EXPERIENCE REPORT |
| 0910-0001 |
Applications for FDA Approval to Market a New Drug |